Holen Sie sich die Stockscreener-App
6.31
13.56%
-0.99
Finanzdaten der Newamsterdam Pharma Company N V-Aktie (NAMSW)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 |
| Periodenlänge | 3 Monate |
| Revenues | |
Operating Expenses
|
|
| Benefits Costs and Expenses | |
| Costs And Expenses | |
| Operating Income/Loss | |
| Income/Loss From Continuing Operations Before Tax | |
| Income/Loss From Continuing Operations After Tax | |
|
Net Income/Loss
|
|
| Preferred Stock Dividends And Other Adjustments | |
| Attributable To Noncontrolling Interest | |
| Basic Average Shares | |
| Diluted Average Shares | |
| Basic Earnings Per Share | |
| Diluted Earnings Per Share | |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
3.01%
Kapitalisierung:
|
Volumen (24h):